112 related articles for article (PubMed ID: 29129511)
1. DMXAA-pyranoxanthone hybrids enhance inhibition activities against human cancer cells with multi-target functions.
Liu J; Zhou F; Zhang L; Wang H; Zhang J; Zhang C; Jiang Z; Li Y; Liu Z; Chen H
Eur J Med Chem; 2018 Jan; 143():1768-1778. PubMed ID: 29129511
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.
Liu J; Zhang J; Wang H; Liu Z; Zhang C; Jiang Z; Chen H
Eur J Med Chem; 2017 Jun; 133():50-61. PubMed ID: 28376372
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.
Liu J; Zhang C; Wang H; Zhang L; Jiang Z; Zhang J; Liu Z; Chen H
Eur J Med Chem; 2018 May; 151():158-172. PubMed ID: 29609121
[TBL] [Abstract][Full Text] [Related]
4. Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone.
Palmeira A; Paiva A; Sousa E; Seca H; Almeida GM; Lima RT; Fernandes MX; Pinto M; Vasconcelos MH
Chem Biol Drug Des; 2010 Jul; 76(1):43-58. PubMed ID: 20456373
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
6. A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel.
França F; Silva PMA; Soares JX; Henriques AC; Loureiro DRP; Azevedo CMG; Afonso CMM; Bousbaa H
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322077
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach.
Leão M; Pereira C; Bisio A; Ciribilli Y; Paiva AM; Machado N; Palmeira A; Fernandes MX; Sousa E; Pinto M; Inga A; Saraiva L
Biochem Pharmacol; 2013 May; 85(9):1234-45. PubMed ID: 23428467
[TBL] [Abstract][Full Text] [Related]
9. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach.
Pan ST; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():937-68. PubMed ID: 25733813
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin.
Antoszczak M; Klejborowska G; Kruszyk M; Maj E; Wietrzyk J; Huczyński A
Chem Biol Drug Des; 2015 Dec; 86(6):1378-86. PubMed ID: 26058448
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-tumor activity evaluation of gallic acid-mangiferin hybrid molecule.
Hu XY; Deng JG; Wang L; Yuan YF
Med Chem; 2013 Dec; 9(8):1058-62. PubMed ID: 23627273
[TBL] [Abstract][Full Text] [Related]
14. Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models.
Azevedo CM; Afonso CM; Soares JX; Reis S; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Gales L; Pinto MM
Eur J Med Chem; 2013 Nov; 69():798-816. PubMed ID: 24113365
[TBL] [Abstract][Full Text] [Related]
15. Studies on chemical-structure modification and structure-activity relationship of gambogic acid derivatives at carbon(34).
Zhang XJ; Li X; Yang YR; Sun HP; Gao Y; Zhang L; Wang JX; Guo QL; You QD
Chem Biodivers; 2012 Oct; 9(10):2295-308. PubMed ID: 23081928
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents.
Tian K; Xu F; Gao X; Han T; Li J; Pan H; Zang L; Li D; Li Z; Uchita T; Gao M; Hua H
Eur J Med Chem; 2017 Aug; 136():131-143. PubMed ID: 28494251
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
18. Heptaoxygenated xanthones as anti-austerity agents from Securidaca longepedunculata.
Dibwe DF; Awale S; Kadota S; Morita H; Tezuka Y
Bioorg Med Chem; 2013 Dec; 21(24):7663-8. PubMed ID: 24216090
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
[TBL] [Abstract][Full Text] [Related]
20. Fundamental, electron transfer mechanism by pyrylium-type ions for the anticancer drugs 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA).
Kovacic P
Curr Med Chem Anticancer Agents; 2005 Sep; 5(5):501-6. PubMed ID: 16178775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
